These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 23525903)
1. Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases. Samaraweera SE; O'Keefe LV; Price GR; Venter DJ; Richards RI Hum Mol Genet; 2013 Jul; 22(14):2811-9. PubMed ID: 23525903 [TBL] [Abstract][Full Text] [Related]
2. Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases. Lawlor KT; O'Keefe LV; Samaraweera SE; van Eyk CL; McLeod CJ; Maloney CA; Dang TH; Suter CM; Richards RI Hum Mol Genet; 2011 Oct; 20(19):3757-68. PubMed ID: 21724553 [TBL] [Abstract][Full Text] [Related]
3. RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases. Richards RI; Samaraweera SE; van Eyk CL; O'Keefe LV; Suter CM Front Mol Neurosci; 2013; 6():25. PubMed ID: 24046729 [TBL] [Abstract][Full Text] [Related]
4. Non-self mutation: double-stranded RNA elicits antiviral pathogenic response in a Drosophila model of expanded CAG repeat neurodegenerative diseases. van Eyk CL; Samaraweera SE; Scott A; Webber DL; Harvey DP; Mecinger O; O'Keefe LV; Cropley JE; Young P; Ho J; Suter C; Richards RI Hum Mol Genet; 2019 Sep; 28(18):3000-3012. PubMed ID: 31071221 [TBL] [Abstract][Full Text] [Related]
5. A Drosophila model of Huntington disease-like 2 exhibits nuclear toxicity and distinct pathogenic mechanisms from Huntington disease. Krench M; Cho RW; Littleton JT Hum Mol Genet; 2016 Aug; 25(15):3164-3177. PubMed ID: 27288455 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitous expression of CUG or CAG trinucleotide repeat RNA causes common morphological defects in a Drosophila model of RNA-mediated pathology. Lawlor KT; O'Keefe LV; Samaraweera SE; van Eyk CL; Richards RI PLoS One; 2012; 7(6):e38516. PubMed ID: 22715390 [TBL] [Abstract][Full Text] [Related]
7. RNA toxicity induced by expanded CAG repeats in Huntington's disease. Martí E Brain Pathol; 2016 Nov; 26(6):779-786. PubMed ID: 27529325 [TBL] [Abstract][Full Text] [Related]
8. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding. Xiao G; Fan Q; Wang X; Zhou B Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14995-5000. PubMed ID: 23980182 [TBL] [Abstract][Full Text] [Related]
9. The pathogenic agent in Drosophila models of 'polyglutamine' diseases. McLeod CJ; O'Keefe LV; Richards RI Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976 [TBL] [Abstract][Full Text] [Related]
10. Modeling and analysis of repeat RNA toxicity in Drosophila. Samaraweera SE; O'Keefe LV; van Eyk CL; Lawlor KT; Humphreys DT; Suter CM; Richards RI Methods Mol Biol; 2013; 1017():173-92. PubMed ID: 23719916 [TBL] [Abstract][Full Text] [Related]
11. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity. Bañez-Coronel M; Porta S; Kagerbauer B; Mateu-Huertas E; Pantano L; Ferrer I; Guzmán M; Estivill X; Martí E PLoS Genet; 2012; 8(2):e1002481. PubMed ID: 22383888 [TBL] [Abstract][Full Text] [Related]
12. AUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease. Billes V; Kovács T; Hotzi B; Manzéger A; Tagscherer K; Komlós M; Tarnóci A; Pádár Z; Erdős A; Bjelik A; Legradi A; Gulya K; Gulyás B; Vellai T J Huntingtons Dis; 2016 May; 5(2):133-47. PubMed ID: 27163946 [TBL] [Abstract][Full Text] [Related]
13. Lack of RAN-mediated toxicity in Huntington's disease knock-in mice. Yang S; Yang H; Huang L; Chen L; Qin Z; Li S; Li XJ Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4411-4417. PubMed ID: 32029588 [TBL] [Abstract][Full Text] [Related]
14. Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture. Zhang X; Abels ER; Redzic JS; Margulis J; Finkbeiner S; Breakefield XO Cell Mol Neurobiol; 2016 Apr; 36(3):459-70. PubMed ID: 26951563 [TBL] [Abstract][Full Text] [Related]
15. Towards a transgenic model of Huntington's disease in a non-human primate. Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016 [TBL] [Abstract][Full Text] [Related]
16. Lessons from animal models of Huntington's disease. Rubinsztein DC Trends Genet; 2002 Apr; 18(4):202-9. PubMed ID: 11932021 [TBL] [Abstract][Full Text] [Related]
17. Genes and pathways affected by CAG-repeat RNA-based toxicity in Drosophila. Shieh SY; Bonini NM Hum Mol Genet; 2011 Dec; 20(24):4810-21. PubMed ID: 21933837 [TBL] [Abstract][Full Text] [Related]
18. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Menzies FM; Garcia-Arencibia M; Imarisio S; O'Sullivan NC; Ricketts T; Kent BA; Rao MV; Lam W; Green-Thompson ZW; Nixon RA; Saksida LM; Bussey TJ; O'Kane CJ; Rubinsztein DC Cell Death Differ; 2015 Mar; 22(3):433-44. PubMed ID: 25257175 [TBL] [Abstract][Full Text] [Related]
19. Comparative toxicity of polyglutamine, polyalanine and polyleucine tracts in Drosophila models of expanded repeat disease. van Eyk CL; McLeod CJ; O'Keefe LV; Richards RI Hum Mol Genet; 2012 Feb; 21(3):536-47. PubMed ID: 22021427 [TBL] [Abstract][Full Text] [Related]
20. Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease. Besson MT; Dupont P; Fridell YW; Liévens JC Hum Mol Genet; 2010 Sep; 19(17):3372-82. PubMed ID: 20566711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]